Say something
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced on Aug 28, 2011 the main results of the Phase 3 clinical trial ARISTOTLE (Apixaban for Reduction In Stroke and Other Thromboembolic Events in Atrial Fibrillation), which uated ELIQUIS
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
India-based clinical laboratory Core Diagnostics on Monday presented its latest findings to treat cancer with the use ...
A non-invasive brainwave mirroring technology has been developed in United States to reduce the symptoms of post-traum...
Researchers from a US university provide new insights on the factors that affect health-related quality of life in older...
The babies of mothers, who do not have diabetes, are equally at risk of developing a congenital heart defect if they hav...
Scientists at Queen Mary University of London have moved a step closer to cure haemophilia -- a genetic disorder that im...
Researchers in the UK have developed a non-invasive technique using standard hospital-based Magnetic Resonance Imaging (...
A team of scientists has found a new combination therapy, developed for the first line treatment of advanced non-squamou...
The brain of a child, the first to undergo a successful hand transplant two years ago, has reverted toward a more typica...
A survey conducted by the Government Medical College and Hospital, Chandigarh, on the occasion of International Day for ...
The diabetes management in Indians require separate attention due to their distinct dietary habits (high carbohydrate co...
